Recent 13F filings as of December 2025 show that 42 institutional investors hold a position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 609,696 | -39,645 | -6.11% | $4,395,908.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 541,228 | 20,506 | 3.94% | $3,902,253.00 |
| Erste Asset Management GmbH | 31 Dec, 2025 | 271,705 | 11,694 | 4.50% | $1,956,354.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 255,539 | 13,710 | 5.67% | $1,842,696.00 |
| STATE STREET CORP | 31 Dec, 2025 | 198,967 | 1,301 | 0.66% | $1,434,552.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 178,140 | 93,334 | 110.06% | $1,284,388.00 |
| Privium Fund Management B.V. | 31 Dec, 2025 | 172,500 | 172,500 | 0.00% | $1,243,725.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 95,799 | 65,798 | 219.32% | $690,711.00 |
| GSA CAPITAL PARTNERS LLP | 31 Dec, 2025 | 77,227 | -8,868 | -10.30% | $557.00 |
| UBS Group AG | 31 Dec, 2025 | 67,341 | 57,393 | 576.93% | $485,528.00 |
| Walleye Capital LLC | 31 Dec, 2025 | 43,878 | 43,878 | 0.00% | $316,360.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 41,100 | 41,100 | 0.00% | $296,331.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 25,300 | 405 | 1.63% | $182,413.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 25,241 | 1,050 | 4.34% | $181,988.00 |
| Nuveen, LLC | 31 Dec, 2025 | 24,497 | 0 | 0.00% | $176,623.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 23,294 | 4,320 | 22.77% | $167,950.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 19,100 | 19,100 | 0.00% | $137,711.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 18,213 | 18,213 | 0.00% | $131,316.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 17,651 | -191 | -1.07% | $127,264.00 |
| Miller Financial Services LLC | 31 Dec, 2025 | 13,643 | 2,000 | 17.18% | $98,366.00 |